NCT06250595View on ClinicalTrials.gov

European Rare Blood Disorders Platform (ENROL)

RecruitingOBSERVATIONAL
Enrollment

37,090

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 31, 2037

Study Completion Date

July 31, 2037

Conditions
AnemiaBone Marrow FailureBleeding DisorderIron Metabolism DisordersMyelomaLymphoid NeoplasmMyeloma, MalignantLeukemiaAnemia, Sickle CellThalassemiaBlood CancerRed Cell Membrane and Enzyme Abnormalities
Interventions
OTHER

Collection of clinical and laboratory data from EHR.

Observational sutdy

Trial Locations (1)

08035

RECRUITING

María del Mar, Barcelona

All Listed Sponsors
collaborator

ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases

UNKNOWN

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER